MedTrace Logo

Nonivamide/Nicoboxil Ointment in Acute Low Back Pain

NCT01708915 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 805

Last updated 2014-05-29

Study results available
· View outcomes & findings →

Summary

The aim of this study is to assess the efficacy and tolerability of Nicoboxil/Nonivamide ointment in comparison to Nicoboxil, Nonivamide, and placebo ointments for the treatment of acute low back pain.

Conditions

  • Acute Low Back Pain

Interventions

DRUG

nicoboxil

2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period

DRUG

placebo matching nonivamide + nicoboxil

2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period

DRUG

nonivamide + nicoboxil (Finalgon)

2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period

DRUG

nonivamide

2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01708915 on ClinicalTrials.gov